Siemens has no plans to withdraw from Russian market — company’s representativeBusiness & Economy July 21, 11:51
Russia to supply another batch of transport helicopters to China in 2018Business & Economy July 21, 11:47
All four turbines produced by Siemens delivered to Crimea despite agreementsBusiness & Economy July 21, 10:11
Records file on Gagarin flight fetches nearly $50,000 at Sotheby’sSociety & Culture July 21, 10:00
Russian-Chinese naval exercises kick off in Baltic SeaMilitary & Defense July 21, 9:47
IMF Executive Board decides on $1.8 billion conditional loan for GreeceBusiness & Economy July 21, 3:34
Turkey’s western coast rocked by 6.7 magnitude quakeWorld July 21, 2:58
ExxonMobil launches legal challenge to finding it violated US sanctions against RussiaBusiness & Economy July 21, 1:36
Russian Knights aerobatic team to perform at Dubai airshowMilitary & Defense July 20, 21:28
VIENNA, April 19. /TASS/. The International Biathlon Union (IBU) forwarded the case of Russian biathlete Eduard Latypov, suspected of taking banned performance enhancing drug meldonium, to the anti-doping commission of the union, asking to clear the Russian athlete of doping charges, IBU’s press service reported on Tuesday.
"The IBU handed over the case of Mr. Latypov to the ADHP [Anti-Doping Hearing Panel] and requested to lift provisional suspension," the IBU’s press service said in a statement.
According to the statement, the request followed recent recommendations issued by the World Anti-Doping Agency regarding meldonium.
WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.
The doping sample of 22-year-old Latypov was collected on February 14 in Osrblie, Slovakia, where he raced to his first international career victory after winning the sprint race at the IBU Cup. His in-competition Sample A tested positive for meldonium.
The drug meldonium (mildronate) was included in the list of preparations banned by the World Anti-Doping Agency from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.